GSK invests in Montrose

GSK’s £54 million new state-of-the-art production building in Montrose has been opened by First Minister Nicola Sturgeon.

Active pharmaceutical ingredients (APIs) for use in GSK’s Ellipta respiratory inhalers will be produced in the building which is the second multi-million investment in the Montrose site over the last two years.

The First Minister said:

“This new facility is testament to GSK’s commitment to Montrose and reinforces the region’s position alongside Singapore as the two sites producing APIs for all of GSK’s Ellipta respiratory inhaler portfolio.

“Scotland has a thriving life sciences community making a significant contribution to the quality of care and health of people in Scotland and around the globe. This immensely innovative sector provides huge economic benefit to Scotland and, with a highly skilled workforce, makes us well placed to take advantage of the economic opportunities from innovation and technological change.”

GSK CEO Emma Walmsley said:

“The state-of-the-art facility we are opening today represents a £54 million investment in GSK Montrose and is testament to the highly-skilled workforce at the site. It also highlights the important part Montrose will play in our future growth, based around our latest medicines for respiratory, HIV and vaccines.

“GSK has a substantial manufacturing presence in Scotland and we’re delighted to welcome the First Minister back to Montrose to mark the next phase of our investment in Angus, and in Scotland’s growing life sciences industry.”

Steve Dunlop, Scottish Enterprise CEO, said:

“The opening of this new facility is a fantastic endorsement of Scotland as a business location.

“Global companies like GSK choose to invest here because we have unrivalled talent to research, develop and manufacture innovative medicines that positively impact lives all over the world.

“We’ll continue to help GSK grow its business locally and nationally to create sustainable and inclusive jobs, and recognise its significant contribution to Scotland’s thriving life sciences sector.”

Background

The First Minister opened GSK’s other Montrose facility last year.